Ginsenoside Rb1 prevents lipopolysaccharide-induced depressive-like behavior by inhibiting inflammation and neural dysfunction and F2 elicits a novel antidepressant-like effect: A metabolite-based network pharmacology study
Author:
Funder
National Key Research and Development Program of China
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference49 articles.
1. The bidirectional relationship of depression and inflammation: double trouble;Beurel;Neuron,2020
2. From inflammation to sickness and depression: when the immune system subjugates the brain;Dantzer;Nat. Rev. Neurosci.,2008
3. The Signal Transducer and Activator of Transcription 1α and Interferon Regulatory Factor 1 Are Not Essential for the Induction of Indoleamine 2,3-Dioxygenase by Lipopolysaccharide: Involvement of p38 Mitogen-Activated Protein Kinase and Nuclear Factor-κB Pathways, and Synergistic Effect of Several Proinflammatory Cytokines
4. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior;Haroon;Neuropsychopharmacology,2012
5. Enzymatic biotransformation of ginsenoside Rb1 and gypenoside XVII into ginsenosides Rd and F2 by recombinant beta-glucosidase from flavobacterium johnsoniae;Hong;J. Ginseng Res.,2012
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Wu-zhu-yu Decoction reduces early brain injury following subarachnoid hemorrhage in vivo and in vitro by activating the Nrf2 antioxidant system via SIRT6 targeting;Journal of Ethnopharmacology;2024-01
2. Therapeutic potential and possible mechanisms of ginseng for depression associated with COVID-19;Inflammopharmacology;2023-11-27
3. Natural products for the treatment of depression: Insights into signal pathways influencing the hypothalamic–pituitary–adrenal axis;Medicine;2023-11-03
4. Regulation of transcriptome networks that mediate ginsenoside biosynthesis by essential ecological factors;PLOS ONE;2023-08-17
5. Neuroprotective Mechanisms of Ginsenoside Rb1 in Central Nervous System Diseases;Frontiers in Pharmacology;2022-06-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3